Skip to main content
Top
Published in: Archives of Virology 6/2012

01-06-2012 | Original Article

Dysregulation of the β3 integrin-VEGFR2 complex in Hantaan virus–directed hyperpermeability upon treatment with VEGF

Authors: Wei Wang, Ye Zhang, Yu Li, Lei Pan, Lu Bai, Yan Zhuang, Chang-Xing Huang, Jiu-Ping Wang, Hai-Tao Yu, Xin Wei, Wei Jiang, Ya-Yun Nan, Dong-Qiang Yang, Wen-Jing Su, Ping-Zhong Wang, Xue-Fan Bai

Published in: Archives of Virology | Issue 6/2012

Login to get access

Abstract

Hantaviruses infect human endothelial cells (ECs) and are known to cause vascular-permeability-based diseases, including hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). The αvβ3 integrins, which are highly expressed on the surface of ECs, serve as hantavirus receptors. Specifically, the β3 integrin and vascular endothelial growth factor (VEGF) receptor 2 (VEGFR2) form a functional complex and interact with each other. Signaling through this complex causes cytoskeletal reorganization, which is one of the most important mechanisms underlying hyperpermeability. In this study, we show that VEGF dramatically enhances Hantaan virus (HTNV)-directed permeability and increases the reorganization of the cytoskeleton and the disruption of junctional organizations in an EC monolayer at 3 days postinfection. HTNV infection reduced the effect of VEGF on adhesion, migration, and the upregulation of β3 expression, but the infection alone upregulated the expression of β3 and VEGFR2. These results indicate that in addition to its role in blocking β3 integrin activation as reported previously, HTNV blocks the function of the complex of VEGFR2 and β3 integrin, and the dysfunction of the complex may contribute to cytoskeletal reorganization in an HTNV-directed hyperpermeability response to VEGF.
Literature
1.
go back to reference Bogatcheva NV, Garcia JG, Verin AD (2002) Role of tyrosine kinase signaling in endothelial cell barrier regulation. Vascul Pharmacol 39:201–212PubMedCrossRef Bogatcheva NV, Garcia JG, Verin AD (2002) Role of tyrosine kinase signaling in endothelial cell barrier regulation. Vascul Pharmacol 39:201–212PubMedCrossRef
2.
go back to reference Bogatcheva NV, Verin AD (2008) The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res 76:202–207PubMedCrossRef Bogatcheva NV, Verin AD (2008) The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res 76:202–207PubMedCrossRef
3.
go back to reference Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039PubMed Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039PubMed
4.
6.
go back to reference Eum SY, Lee YW, Hennig B, Toborek M (2004) VEGF regulates PCB 104-mediated stimulation of permeability and transmigration of breast cancer cells in human microvascular endothelial cells. Exp Cell Res 296:231–244PubMedCrossRef Eum SY, Lee YW, Hennig B, Toborek M (2004) VEGF regulates PCB 104-mediated stimulation of permeability and transmigration of breast cancer cells in human microvascular endothelial cells. Exp Cell Res 296:231–244PubMedCrossRef
7.
go back to reference Fuse C, Ishida Y, Hikita T, Asai T, Oku N (2007) Junctional adhesion molecule-C promotes metastatic potential of HT1080 human fibrosarcoma. J Biol Chem 282:8276–8283PubMedCrossRef Fuse C, Ishida Y, Hikita T, Asai T, Oku N (2007) Junctional adhesion molecule-C promotes metastatic potential of HT1080 human fibrosarcoma. J Biol Chem 282:8276–8283PubMedCrossRef
8.
go back to reference Gavrilovskaya IN, Shepley M, Shaw R, Ginsberg MH, Mackow ER (1998) beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci USA 95:7074–7079PubMedCrossRef Gavrilovskaya IN, Shepley M, Shaw R, Ginsberg MH, Mackow ER (1998) beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci USA 95:7074–7079PubMedCrossRef
9.
go back to reference Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER (1999) Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol 73:3951–3959PubMed Gavrilovskaya IN, Brown EJ, Ginsberg MH, Mackow ER (1999) Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol 73:3951–3959PubMed
10.
go back to reference Gavrilovskaya IN, Peresleni T, Geimonen E, Mackow ER (2002) Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration. Arch Virol 147:1913–1931PubMedCrossRef Gavrilovskaya IN, Peresleni T, Geimonen E, Mackow ER (2002) Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration. Arch Virol 147:1913–1931PubMedCrossRef
11.
go back to reference Gavrilovskaya IN, Gorbunova EE, Mackow NA, Mackow ER (2008) Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J Virol 82:5797–5806PubMedCrossRef Gavrilovskaya IN, Gorbunova EE, Mackow NA, Mackow ER (2008) Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J Virol 82:5797–5806PubMedCrossRef
12.
go back to reference Geiger B, Bershadsky A, Pankov R, Yamada KM (2001) Transmembrane crosstalk between the extracellular matrix–cytoskeleton crosstalk. Natl Rev Mol Cell Biol 2:793–805CrossRef Geiger B, Bershadsky A, Pankov R, Yamada KM (2001) Transmembrane crosstalk between the extracellular matrix–cytoskeleton crosstalk. Natl Rev Mol Cell Biol 2:793–805CrossRef
13.
go back to reference Lee HW (1982) Hemorrhagic fever with renal syndrome (HFRS). Scand J Infect Dis 36:82–85 Lee HW (1982) Hemorrhagic fever with renal syndrome (HFRS). Scand J Infect Dis 36:82–85
14.
go back to reference Larson RS, Brown DC, Ye C, Hjelle B (2005) Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor. J Virol 79:7319–7326PubMedCrossRef Larson RS, Brown DC, Ye C, Hjelle B (2005) Peptide antagonists that inhibit Sin Nombre virus and hantaan virus entry through the beta3-integrin receptor. J Virol 79:7319–7326PubMedCrossRef
15.
go back to reference LeDuc JW, Childs CJ, Glass GE (1992) The Hantaviruses, etiologic agents of hemorrhagic fever with renal syndrome: a possible cause of hypertension and chronic renal disease in the United States. Annu Rev Public Health 13:79–98PubMedCrossRef LeDuc JW, Childs CJ, Glass GE (1992) The Hantaviruses, etiologic agents of hemorrhagic fever with renal syndrome: a possible cause of hypertension and chronic renal disease in the United States. Annu Rev Public Health 13:79–98PubMedCrossRef
16.
go back to reference Mackow ER, Gavrilovskaya IN (2001) Cellular receptors and hantavirus pathogenesis. Curr Top Microbiol Immunol 256:91–115PubMedCrossRef Mackow ER, Gavrilovskaya IN (2001) Cellular receptors and hantavirus pathogenesis. Curr Top Microbiol Immunol 256:91–115PubMedCrossRef
17.
go back to reference Mahabeleshwar GH, Feng W, Phillips DR, Byzova TV (2006) Integrin signaling is critical for pathological angiogenesis. J Exp Med 203:2495–2507PubMedCrossRef Mahabeleshwar GH, Feng W, Phillips DR, Byzova TV (2006) Integrin signaling is critical for pathological angiogenesis. J Exp Med 203:2495–2507PubMedCrossRef
18.
go back to reference Mou DL, Wang YP, Huang CX, Li GY, Pan L, Yang WS, Bai XF (2006) Cellular entry of Hantaan virus A9 strain: specific interactions with beta3 integrins and a novel 70kDa protein. Biochem Biophys Res Commun 339:611–617PubMedCrossRef Mou DL, Wang YP, Huang CX, Li GY, Pan L, Yang WS, Bai XF (2006) Cellular entry of Hantaan virus A9 strain: specific interactions with beta3 integrins and a novel 70kDa protein. Biochem Biophys Res Commun 339:611–617PubMedCrossRef
19.
go back to reference Orr FW, Wang HH, Lafrenie RM, Scherbarth S, Nance DM (2000) Interactions between cancer cells and the endothelium in metastasis. J Pathol 190:310–329PubMedCrossRef Orr FW, Wang HH, Lafrenie RM, Scherbarth S, Nance DM (2000) Interactions between cancer cells and the endothelium in metastasis. J Pathol 190:310–329PubMedCrossRef
20.
go back to reference Palecek SP, Horwitz AF, Lauffenburger DA (1999) Kinetic model for integrin-mediated adhesion release during cell migration. Ann Biomed Eng 27:219–235PubMedCrossRef Palecek SP, Horwitz AF, Lauffenburger DA (1999) Kinetic model for integrin-mediated adhesion release during cell migration. Ann Biomed Eng 27:219–235PubMedCrossRef
21.
go back to reference Plopper GE, McNamee HP, Dike LE, Bojanowski K, Ingber DE (1995) Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Biol Cell 6:1349–1365PubMed Plopper GE, McNamee HP, Dike LE, Bojanowski K, Ingber DE (1995) Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Biol Cell 6:1349–1365PubMed
22.
go back to reference Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, Bussolino F (1999) Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 18:882–892PubMedCrossRef Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, Bussolino F (1999) Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 18:882–892PubMedCrossRef
23.
go back to reference Stewart PL, Nemerow GR (2007) Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol 15:500–507PubMedCrossRef Stewart PL, Nemerow GR (2007) Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol 15:500–507PubMedCrossRef
24.
go back to reference Sugimori T, Griffith DL, Arnaout MA (1997) Emerging paradigms of integrin ligand binding and activation. Kidney Int 51:1454–1462PubMedCrossRef Sugimori T, Griffith DL, Arnaout MA (1997) Emerging paradigms of integrin ligand binding and activation. Kidney Int 51:1454–1462PubMedCrossRef
25.
go back to reference Valbuena G, Walker DH (2006) The endothelium as a target for infections. Annu Rev Pathol 1:171–198PubMedCrossRef Valbuena G, Walker DH (2006) The endothelium as a target for infections. Annu Rev Pathol 1:171–198PubMedCrossRef
27.
go back to reference Yamada KM, Even-Ram S (2002) Integrin regulation of growth factor receptors. Nat Cell Biol 4:E75–E76PubMedCrossRef Yamada KM, Even-Ram S (2002) Integrin regulation of growth factor receptors. Nat Cell Biol 4:E75–E76PubMedCrossRef
28.
go back to reference Zachary I, Gliki G (2001) Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 49:568–581PubMedCrossRef Zachary I, Gliki G (2001) Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc Res 49:568–581PubMedCrossRef
Metadata
Title
Dysregulation of the β3 integrin-VEGFR2 complex in Hantaan virus–directed hyperpermeability upon treatment with VEGF
Authors
Wei Wang
Ye Zhang
Yu Li
Lei Pan
Lu Bai
Yan Zhuang
Chang-Xing Huang
Jiu-Ping Wang
Hai-Tao Yu
Xin Wei
Wei Jiang
Ya-Yun Nan
Dong-Qiang Yang
Wen-Jing Su
Ping-Zhong Wang
Xue-Fan Bai
Publication date
01-06-2012
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 6/2012
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-012-1245-7

Other articles of this Issue 6/2012

Archives of Virology 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine